Follicular lymphoma: The long and winding road leading to your cure?
Year: 2022
Type: review
Source: Blood Reviews
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: follicular lymphoma, indolent lymphoma, epigenetic mutations, EZH2, KMT2D, CREB-binding protein, EP300, B cell receptor signaling, Ras, mTOR, JAK/STAT signaling, immune evasion, tumor microenvironment, relapsed follicular lymphoma, anti-CD20 monoclonal antibody, tafasitamab, polatuzumab vedotin, magrolimab, lenalidomide, PI3K inhibitors, BTK inhibitors, tazemetostat, histone deacetylase inhibitors, targeted therapy, immunotherapy
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W4286776313
